Rapid Micro Biosystems (NASDAQ:RPID) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Rapid Micro Biosystems (NASDAQ:RPID) from a sell rating to a hold rating in a research report report published on Monday morning.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $8.00.

Rapid Micro Biosystems Stock Down 2.5%

Shares of RPID stock opened at $3.06 on Monday. Rapid Micro Biosystems has a twelve month low of $0.98 and a twelve month high of $4.50. The stock has a market cap of $135.62 million, a P/E ratio of -3.03 and a beta of 1.36. The stock has a 50 day moving average of $3.53 and a 200 day moving average of $3.32. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42.

Rapid Micro Biosystems (NASDAQ:RPID) last released its quarterly earnings data on Friday, November 7th. The company reported ($0.26) EPS for the quarter, hitting the consensus estimate of ($0.26). The business had revenue of $7.84 million for the quarter, compared to analyst estimates of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. As a group, sell-side analysts expect that Rapid Micro Biosystems will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Evernest Financial Advisors LLC lifted its stake in Rapid Micro Biosystems by 355.1% in the 3rd quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock valued at $669,000 after buying an additional 156,234 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Rapid Micro Biosystems by 6.7% during the third quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock valued at $3,223,000 after acquiring an additional 60,655 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of Rapid Micro Biosystems in the second quarter valued at approximately $144,000. Dimensional Fund Advisors LP lifted its position in shares of Rapid Micro Biosystems by 37.8% in the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock valued at $186,000 after acquiring an additional 15,255 shares in the last quarter. Finally, American Century Companies Inc. acquired a new stake in shares of Rapid Micro Biosystems in the first quarter worth approximately $31,000. Institutional investors and hedge funds own 52.60% of the company’s stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.